Catherine Novack
Stock Analyst at Jones Trading
(1.72)
# 3,083
Out of 4,711 analysts
16
Total ratings
28.57%
Success rate
-3.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Initiates: Buy | $130 | $43.67 | +197.69% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $13.07 | +206.04% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.61 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $13.51 | +18.43% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $4.01 | +249.13% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $2.71 | +379.70% | 2 | Aug 16, 2024 | |
| RGLS Regulus Therapeutics | Initiates: Buy | $8 | $1.59 | +403.14% | 1 | May 31, 2024 | |
| RZLT Rezolute | Initiates: Buy | $10 | $4.39 | +127.79% | 1 | Apr 18, 2024 | |
| FEMY Femasys | Maintains: Buy | $7 → $10 | $1.09 | +817.43% | 1 | Mar 20, 2024 | |
| CALC CalciMedica | Initiates: Buy | $22 | $2.76 | +697.10% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.38 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $3.42 | +4,578.36% | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.84 | +1,214.37% | 1 | Mar 10, 2023 |
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $43.67
Upside: +197.69%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $13.07
Upside: +206.04%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.61
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $13.51
Upside: +18.43%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.01
Upside: +249.13%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.71
Upside: +379.70%
Regulus Therapeutics
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $1.59
Upside: +403.14%
Rezolute
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.39
Upside: +127.79%
Femasys
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.09
Upside: +817.43%
CalciMedica
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $2.76
Upside: +697.10%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.38
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $3.42
Upside: +4,578.36%
Mar 10, 2023
Initiates: Buy
Price Target: $11
Current: $0.84
Upside: +1,214.37%